In an orthotopic model of breast cancer, treatment with decitabine showed PKD1-independent effects on primary tumor growth, probably due in part to a decrease of cell proliferation and an increase of apoptosis[45-48], as indicated by staining of Ki-67 and cleaved PARP (Additional file7: Figure S6). The gene discussed is PKD1; the disease is breast cancer.